Synergistic cytokine effects as apremilast response predictors in patients with psoriasis - 06/09/18
Doi : 10.1016/j.jaci.2018.05.039
Sandra Garcet, PhD a, Kristine Nograles, MD b, Joel Correa da Rosa, PhD a, Peter H. Schafer, PhD c, James G. Krueger, MD, PhD a 
a Laboratory of Investigative Dermatology, The Rockefeller University, New York, NY
b Clinical Research and Development, Celgene Corporation, Summit, NJ
c Department of Translational Development, Celgene Corporation, Summit, NJ
| This study was sponsored by Celgene Corporation. |
|
| Disclosure of potential conflict of interest: K. Nograles and P. H. Schafer are employees of and own stock in Celgene Corporation. J. G. Krueger has received grant/research support from AbbVie, Amgen, BMS, Boehringer Ingelheim, EMD Serono, Innovaderm, Kineta, LEO Pharma, Novan, Novartis, Paraxel, Pfizer, Regeneron, and Vitae Pharmaceuticals, and has received personal fees from AbbVie, Acros, Allergan, Aurigene, Biogen Idec, Boehringer Ingelheim, Eli Lilly, Escalier Biosciences, Janssen, Novartis, Pfizer, Roche, and Valeant. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2018
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 142 - N° 3
P. 1010 - septembre 2018 Retour au numéro
Article précédent
- Mast cell activation syndrome: Importance of consensus criteria and call for research
- Peter Valent, Cem Akin, Patrizia Bonadonna, Karin Hartmann, Sigurd Broesby-Olsen, Knut Brockow, Joseph H. Butterfield, Andreas Reiter, Jason Gotlib, Mariana Castells, Joshua D. Milner, Melody C. Carter, Hirsh Komarow, Deepti Radia, Animesh Pardanani, Karl Sotlar, Massimo Triggiani, Hans-Peter Horny, Michel Arock, Lawrence B. Schwartz, Dean D. Metcalfe
- Atopic dermatitis in Chinese patients shows TH2/TH17 skewing with psoriasiform features
- Tom C. Chan, Riana D. Sanyal, Ana B. Pavel, Jacob Glickman, Xiuzhong Zheng, Hui Xu, Yung-Tsu Cho, Tsen-Feng Tsai, Huei-Chi Wen, Xiangyu Peng, Inna Cueto, James G. Krueger, Emma Guttman-Yassky
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?